A clinical trial to see the Effectiveness of potentized homeopathic medicine Lycopus virginica 30c in patients of Primary Hypertension in the age group of 30-70 years.
Dr.Nirmala sharma
, Dr. Zunnun Ali , Dr.Devendra Nama , Dr. Somnath D. Pande
Lycopus Virginica, Homoeopathy, silent killer, hypertensive-sinogenic factors.
ABSTRACT: According to the World Health Organization (WHO), hypertension (HTN) is one of the most prevalent health problems in today's expanding population. Research indicates that only 5% of people have secondary hypertension and that 85–95% of people have essential hypertension. Nonetheless, homoeopathy is utilized as a substitute in these situations, namely HTN, and it produces excellent therapeutic outcomes in HTN instances. Although very little study has been done to support it, Lycopus Virginica lowers the blood pressure, reduce the rate of heart and increase the length of systole to a great degree. This is a heart remedy Indicated in pulse weak, Irregular, Intermittent, tremulous and rapid. The purpose of this study was to determine whether or not essential hypertension individuals' blood pressure can be lowered by the homoeopathic medication Lycopus Virginica 30C. This is a single arm, single blind, monocentric phase II clinical trial. A total of 40 individuals, both male and female, ranging in age from 30 to 70 years, were included in this investigation. Of them, 30 patients finished their follow-up and 10 patients were discontinued. The patient was seated when their blood pressure was taken. After 10–12 weeks of outpatient therapy, the blood pressure finally decreased. Significant drops in hypertension patients' blood pressure were seen both before and after treatment, and the patients' symptoms were also alleviated. Lycopus virginica 30C, a homoeopathic medication, significantly lowered blood pressure in critical hypertension patients.
"A clinical trial to see the Effectiveness of potentized homeopathic medicine Lycopus virginica 30c in patients of Primary Hypertension in the age group of 30-70 years.", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.9, Issue 5, page no.527 - 530, May-2024, Available :https://ijsdr.org/papers/IJSDR2405075.pdf
Volume 9
Issue 5,
May-2024
Pages : 527 - 530
Paper Reg. ID: IJSDR_211358
Published Paper Id: IJSDR2405075
Downloads: 000347474
Research Area: Medical Science
Country: Bhilwara, Rajasthan, India
ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJSDR(IJ Publication) Janvi Wave
